Shields Matthew sold TEVA
June 18, 2026 · Form 4 insider transaction
Shields Matthew sold 9,989 shares of Teva Pharmaceutical Industries Limited at $32.19 per share, a transaction worth $321.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
9,989
Price
$32.19
Total value
$321.5K
InsiderShields Matthew
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJune 18, 2026
Filing dateJune 22, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.